NO320625B1 - Analytisk element samt analytisk flerlagselement og fremgangsmate for bestemmelse av en spesifikk bindingsligand ved bruk av vanadiumbromperoksydase som et signalgenererende enzym - Google Patents

Analytisk element samt analytisk flerlagselement og fremgangsmate for bestemmelse av en spesifikk bindingsligand ved bruk av vanadiumbromperoksydase som et signalgenererende enzym Download PDF

Info

Publication number: NO320625B1
Authority: NO; Norway
Prior art keywords: specific binding; vanadium; vanadium bromoperoxidase; binding ligand; halogen
Prior art date: 1995-09-01

Application number

NO19980813A

Other languages

English (en)

Norwegian (no)

Other versions

NO980813L (no

NO980813D0 (no

Inventor

Alan Eric Friedman

Sarah Fingar Groulx

Thomas Robert Kissel

Martha Miller Kopcienski

Original Assignee

Ortho Clinical Diagnostics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-01

Filing date

1998-02-26

Publication date

2006-01-02

1998-02-26 Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc

1998-02-26 Publication of NO980813D0 publication Critical patent/NO980813D0/no

1998-04-23 Publication of NO980813L publication Critical patent/NO980813L/no

2006-01-02 Publication of NO320625B1 publication Critical patent/NO320625B1/no

Links

239000003446 ligand Substances 0.000 title claims abstract description 45
230000009870 specific binding Effects 0.000 title claims abstract description 28
238000000034 method Methods 0.000 title claims description 27
102000004190 Enzymes Human genes 0.000 title description 21
108090000790 Enzymes Proteins 0.000 title description 21
229910052720 vanadium Inorganic materials 0.000 title description 2
LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 claims abstract description 49
108010073997 Bromide peroxidase Proteins 0.000 claims abstract description 46
239000003153 chemical reaction reagent Substances 0.000 claims abstract description 31
229910052736 halogen Inorganic materials 0.000 claims abstract description 16
125000002577 pseudohalo group Chemical group 0.000 claims abstract description 16
150000002367 halogens Chemical class 0.000 claims abstract description 14
150000002978 peroxides Chemical class 0.000 claims abstract description 11
KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical class C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 claims abstract description 5
239000012530 fluid Substances 0.000 claims description 34
239000000463 material Substances 0.000 claims description 24
238000005406 washing Methods 0.000 claims description 21
239000002250 absorbent Substances 0.000 claims description 11
230000002745 absorbent Effects 0.000 claims description 11
239000000872 buffer Substances 0.000 claims description 10
108040007629 peroxidase activity proteins Proteins 0.000 claims description 9
238000009792 diffusion process Methods 0.000 claims description 8
FYMBCBXJSPPHJQ-UHFFFAOYSA-N [Br].[V] Chemical compound [Br].[V] FYMBCBXJSPPHJQ-UHFFFAOYSA-N 0.000 claims description 7
239000006185 dispersion Substances 0.000 claims description 7
241000512259 Ascophyllum nodosum Species 0.000 claims description 6
230000004044 response Effects 0.000 claims description 5
230000000694 effects Effects 0.000 claims description 4
238000000926 separation method Methods 0.000 claims description 4
241001491621 Corallina officinalis Species 0.000 claims description 3
241001312951 Corallina pilulifera Species 0.000 claims description 3
241000195478 Fucus distichus Species 0.000 claims description 3
241001491705 Macrocystis pyrifera Species 0.000 claims description 3
102000003992 Peroxidases Human genes 0.000 claims description 3
241000983746 Saccharina latissima Species 0.000 claims description 3
230000003197 catalytic effect Effects 0.000 claims description 3
MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 3
BRDWIEOJOWJCLU-LTGWCKQJSA-N GS-441524 Chemical compound C=1C=C2C(N)=NC=NN2C=1[C@]1(C#N)O[C@H](CO)[C@@H](O)[C@H]1O BRDWIEOJOWJCLU-LTGWCKQJSA-N 0.000 claims description 2
238000003556 assay Methods 0.000 abstract description 6
238000002820 assay format Methods 0.000 abstract description 2
230000002860 competitive effect Effects 0.000 abstract 1
-1 antibodies Proteins 0.000 description 34
108010001336 Horseradish Peroxidase Proteins 0.000 description 17
238000003018 immunoassay Methods 0.000 description 17
239000000243 solution Substances 0.000 description 16
239000011248 coating agent Substances 0.000 description 10
238000000576 coating method Methods 0.000 description 9
102000013415 peroxidase activity proteins Human genes 0.000 description 8
238000001514 detection method Methods 0.000 description 7
229910052751 metal Inorganic materials 0.000 description 7
239000002184 metal Substances 0.000 description 7
239000002245 particle Substances 0.000 description 7
230000011664 signaling Effects 0.000 description 7
101710165631 Dihydropyrimidine dehydrogenase [NADP(+)] Proteins 0.000 description 6
101710183660 NAD-dependent dihydropyrimidine dehydrogenase subunit PreA Proteins 0.000 description 6
101710183648 NAD-dependent dihydropyrimidine dehydrogenase subunit PreT Proteins 0.000 description 6
150000001875 compounds Chemical class 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
230000035945 sensitivity Effects 0.000 description 6
238000003892 spreading Methods 0.000 description 6
230000007480 spreading Effects 0.000 description 6
239000000126 substance Substances 0.000 description 6
238000004458 analytical method Methods 0.000 description 5
239000003623 enhancer Substances 0.000 description 5
239000007788 liquid Substances 0.000 description 5
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 5
239000003550 marker Substances 0.000 description 5
JULKJDRBSRRBHT-UHFFFAOYSA-N n-(3-chloro-4-hydroxyphenyl)acetamide Chemical compound CC(=O)NC1=CC=C(O)C(Cl)=C1 JULKJDRBSRRBHT-UHFFFAOYSA-N 0.000 description 5
QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
125000005021 aminoalkenyl group Chemical group 0.000 description 4
239000011324 bead Substances 0.000 description 4
239000011230 binding agent Substances 0.000 description 4
125000004432 carbon atom Chemical group C* 0.000 description 4
WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 4
239000011521 glass Substances 0.000 description 4
229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 4
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
229960003330 pentetic acid Drugs 0.000 description 4
JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical group [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 4
239000011550 stock solution Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
102000011923 Thyrotropin Human genes 0.000 description 3
108010061174 Thyrotropin Proteins 0.000 description 3
229920004890 Triton X-100 Polymers 0.000 description 3
125000003545 alkoxy group Chemical group 0.000 description 3
125000005210 alkyl ammonium group Chemical group 0.000 description 3
125000005001 aminoaryl group Chemical group 0.000 description 3
238000009739 binding Methods 0.000 description 3
239000013060 biological fluid Substances 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
230000009137 competitive binding Effects 0.000 description 3
238000000151 deposition Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
239000003814 drug Substances 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
239000011734 sodium Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
SXGZJKUKBWWHRA-UHFFFAOYSA-N 2-(N-morpholiniumyl)ethanesulfonate Chemical compound [O-]S(=O)(=O)CC[NH+]1CCOCC1 SXGZJKUKBWWHRA-UHFFFAOYSA-N 0.000 description 2
VJEZYZLITKUTFH-UHFFFAOYSA-N 2-(hydrazinecarbonyl)benzoic acid Chemical class NNC(=O)C1=CC=CC=C1C(O)=O VJEZYZLITKUTFH-UHFFFAOYSA-N 0.000 description 2
MWRHOPMYLRWJGK-UHFFFAOYSA-N 3-(hydrazinecarbonyl)anthracene-2-carboxylic acid Chemical class C1=CC=C2C=C(C=C(C(C(=O)NN)=C3)C(O)=O)C3=CC2=C1 MWRHOPMYLRWJGK-UHFFFAOYSA-N 0.000 description 2
NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
108010074051 C-Reactive Protein Proteins 0.000 description 2
102100032752 C-reactive protein Human genes 0.000 description 2
FLVMDDSFLMTEMB-UHFFFAOYSA-N C=1(C(=CC=C2C3=CC=CC=C3CC=12)C(=O)O)C(=O)NN Chemical class C=1(C(=CC=C2C3=CC=CC=C3CC=12)C(=O)O)C(=O)NN FLVMDDSFLMTEMB-UHFFFAOYSA-N 0.000 description 2
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
229920001410 Microfiber Polymers 0.000 description 2
108700020962 Peroxidase Proteins 0.000 description 2
CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
238000007792 addition Methods 0.000 description 2
125000003342 alkenyl group Chemical group 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
125000005605 benzo group Chemical group 0.000 description 2
239000006177 biological buffer Substances 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
239000002131 composite material Substances 0.000 description 2
CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
230000008021 deposition Effects 0.000 description 2
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
229960005156 digoxin Drugs 0.000 description 2
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
238000001035 drying Methods 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
230000005281 excited state Effects 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
150000002736 metal compounds Chemical class 0.000 description 2
239000003658 microfiber Substances 0.000 description 2
229910052755 nonmetal Inorganic materials 0.000 description 2
DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 2
229960002695 phenobarbital Drugs 0.000 description 2
229960002036 phenytoin Drugs 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
229920000139 polyethylene terephthalate Polymers 0.000 description 2
239000005020 polyethylene terephthalate Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
239000000047 product Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
230000005855 radiation Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
238000003860 storage Methods 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
IVYDZBRMECSWSH-UHFFFAOYSA-N 1-(hydrazinecarbonyl)naphthalene-2-carboxylic acid Chemical class C1=CC=C2C(C(=O)NN)=C(C(O)=O)C=CC2=C1 IVYDZBRMECSWSH-UHFFFAOYSA-N 0.000 description 1
YQWVMCHRSYVNMC-UHFFFAOYSA-N 1-(hydrazinecarbonyl)phenanthrene-2-carboxylic acid Chemical class C1=CC2=CC=CC=C2C2=C1C(C(=O)NN)=C(C(O)=O)C=C2 YQWVMCHRSYVNMC-UHFFFAOYSA-N 0.000 description 1
SAVMNSHHXUMFRQ-UHFFFAOYSA-N 1-[bis(ethenylsulfonyl)methoxy-ethenylsulfonylmethyl]sulfonylethene Chemical group C=CS(=O)(=O)C(S(=O)(=O)C=C)OC(S(=O)(=O)C=C)S(=O)(=O)C=C SAVMNSHHXUMFRQ-UHFFFAOYSA-N 0.000 description 1
125000006017 1-propenyl group Chemical group 0.000 description 1
KLHVKSXCTICWSO-UHFFFAOYSA-N 2-(hydrazinecarbonyl)coronene-1-carboxylic acid Chemical class C1(=C(C2=CC=C3C=CC4=CC=C5C=CC6=CC=C1C1=C6C5=C4C3=C21)C(=O)O)C(=O)NN KLHVKSXCTICWSO-UHFFFAOYSA-N 0.000 description 1
229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
125000006040 2-hexenyl group Chemical group 0.000 description 1
PJFNNMFXEVADGK-UHFFFAOYSA-N 2-hydroxy-n-phenylacetamide Chemical compound OCC(=O)NC1=CC=CC=C1 PJFNNMFXEVADGK-UHFFFAOYSA-N 0.000 description 1
BEADQYOTAORBKI-UHFFFAOYSA-N 6-[6-aminohexyl(ethyl)amino]-2,3-dihydrophthalazine-1,4-dione Chemical compound O=C1NNC(=O)C=2C1=CC(N(CCCCCCN)CC)=CC=2 BEADQYOTAORBKI-UHFFFAOYSA-N 0.000 description 1
KPXVMEHUAOLERT-UHFFFAOYSA-N 7-(dimethylamino)-1-(hydrazinecarbonyl)naphthalene-2-carboxylic acid Chemical compound C1=CC(C(O)=O)=C(C(=O)NN)C2=CC(N(C)C)=CC=C21 KPXVMEHUAOLERT-UHFFFAOYSA-N 0.000 description 1
LEOJISUPFSWNMA-UHFFFAOYSA-N ABEI Chemical compound O=C1NNC(=O)C=2C1=CC(N(CCCCN)CC)=CC=2 LEOJISUPFSWNMA-UHFFFAOYSA-N 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical class [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102000011022 Chorionic Gonadotropin Human genes 0.000 description 1
108010062540 Chorionic Gonadotropin Proteins 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
241000233866 Fungi Species 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
KKCIOUWDFWQUBT-AWEZNQCLSA-N L-thyronine Chemical class C1=CC(C[C@H](N)C(O)=O)=CC=C1OC1=CC=C(O)C=C1 KKCIOUWDFWQUBT-AWEZNQCLSA-N 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000000853 adhesive Substances 0.000 description 1
230000001070 adhesive effect Effects 0.000 description 1
125000003368 amide group Chemical group 0.000 description 1
239000012491 analyte Substances 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
230000027455 binding Effects 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
229960000623 carbamazepine Drugs 0.000 description 1
125000001589 carboacyl group Chemical group 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
MYPYJXKWCTUITO-KIIOPKALSA-N chembl3301825 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)C(O)[C@H](C)O1 MYPYJXKWCTUITO-KIIOPKALSA-N 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000003750 conditioning effect Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229960003624 creatine Drugs 0.000 description 1
239000006046 creatine Substances 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
OJOSABWCUVCSTQ-UHFFFAOYSA-N cyclohepta-2,4,6-trienylium Chemical compound C1=CC=C[CH+]=C[CH]1 OJOSABWCUVCSTQ-UHFFFAOYSA-N 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940084986 human chorionic gonadotropin Drugs 0.000 description 1
OAKJQQAXSVQMHS-UHFFFAOYSA-O hydrazinium(1+) Chemical compound [NH3+]N OAKJQQAXSVQMHS-UHFFFAOYSA-O 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
150000002432 hydroperoxides Chemical class 0.000 description 1
238000013198 immunometric assay Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
235000013980 iron oxide Nutrition 0.000 description 1
VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
238000002955 isolation Methods 0.000 description 1
150000002527 isonitriles Chemical class 0.000 description 1
125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
238000001540 jet deposition Methods 0.000 description 1
230000001926 lymphatic effect Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000000178 monomer Substances 0.000 description 1
DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
239000004081 narcotic agent Substances 0.000 description 1
UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
150000001451 organic peroxides Chemical class 0.000 description 1
239000007800 oxidant agent Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical compound [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 description 1
239000011236 particulate material Substances 0.000 description 1
230000003617 peroxidasic effect Effects 0.000 description 1
150000004965 peroxy acids Chemical class 0.000 description 1
XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical compound OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 1
KIZSMODMWVZSNT-UHFFFAOYSA-N perylene-1,2-dicarboxylic acid Chemical compound C1=CC(C2=C(C(C(=O)O)=CC=3C2=C2C=CC=3)C(O)=O)=C3C2=CC=CC3=C1 KIZSMODMWVZSNT-UHFFFAOYSA-N 0.000 description 1
MENZDKNKKCHGMN-UHFFFAOYSA-N phenanthrene-1-carbohydrazide Chemical class C1=CC2=CC=CC=C2C2=C1C(C(=O)NN)=CC=C2 MENZDKNKKCHGMN-UHFFFAOYSA-N 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
YSZIOXAEADAJLX-UHFFFAOYSA-N phthalazine-1,4-dione Chemical class C1=CC=C2C(=O)N=NC(=O)C2=C1 YSZIOXAEADAJLX-UHFFFAOYSA-N 0.000 description 1
210000002381 plasma Anatomy 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
239000004848 polyfunctional curative Substances 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
150000003141 primary amines Chemical group 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000001055 reflectance spectroscopy Methods 0.000 description 1
238000005070 sampling Methods 0.000 description 1
125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
150000003335 secondary amines Chemical group 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000010865 sewage Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium Chemical compound [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
229920001059 synthetic polymer Polymers 0.000 description 1
229960003080 taurine Drugs 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000003512 tertiary amines Chemical group 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
229940034208 thyroxine Drugs 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
229960000707 tobramycin Drugs 0.000 description 1
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
238000002235 transmission spectroscopy Methods 0.000 description 1
238000011282 treatment Methods 0.000 description 1
229940035722 triiodothyronine Drugs 0.000 description 1
AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

NO19980813A 1995-09-01 1998-02-26 Analytisk element samt analytisk flerlagselement og fremgangsmate for bestemmelse av en spesifikk bindingsligand ved bruk av vanadiumbromperoksydase som et signalgenererende enzym NO320625B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US52304295A	1995-09-01	1995-09-01
PCT/US1996/013270 WO1997009619A1 (en)	1995-09-01	1996-08-16	Analytical element and method for the determination of a specific binding ligand using a vanadium bromoperoxidase as a signal-generating enzyme

Publications (3)

Publication Number	Publication Date
NO980813D0 NO980813D0 (no)	1998-02-26
NO980813L NO980813L (no)	1998-04-23
NO320625B1 true NO320625B1 (no)	2006-01-02

Family

ID=24083443

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19980813A NO320625B1 (no)	1995-09-01	1998-02-26	Analytisk element samt analytisk flerlagselement og fremgangsmate for bestemmelse av en spesifikk bindingsligand ved bruk av vanadiumbromperoksydase som et signalgenererende enzym

Country Status (10)

Country	Link
US (1)	US6322992B1 (de)
EP (1)	EP0848819B1 (de)
KR (1)	KR100383141B1 (de)
CN (1)	CN1113105C (de)
AT (1)	ATE192237T1 (de)
AU (1)	AU714498B2 (de)
CA (1)	CA2230802C (de)
DE (1)	DE69607972T2 (de)
NO (1)	NO320625B1 (de)
WO (1)	WO1997009619A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2234999A1 (en) *	1997-04-25	1998-10-25	Dennis D. Carlton	Process for the purification of vanadium bromoperoxidase
DE19718361A1 (de) *	1997-05-02	1998-11-05	Dade Behring Marburg Gmbh	Immunoassay zur Aviditätsbestimmung von Immunglobulinen
US6232457B1 (en) *	1998-09-10	2001-05-15	The Regents Of The University Of California	Recombinant vanadium haloperoxidases and their uses
DE19910045A1 (de) *	1999-03-08	2000-09-14	Mikrogen Molekularbiol Entw	Verfahren zur Bestimmung der Avidität von Antikörpern
DE19918636A1 (de) *	1999-04-23	2000-10-26	Intermedical S A H	Verfahren zum lumineszenten Nachweis von Antigenen
FR2839364B1 (fr) *	2002-05-03	2004-12-24	Commissariat Energie Atomique	Procede de detection d'une reconnaissance molecukaire par electrochimiluminescence
CN101473216B (zh) *	2006-05-09	2011-02-09	贝克曼考尔特公司	非分离式测定方法
CN106148364A (zh) *	2016-07-18	2016-11-23	中国海洋大学	海带钒离子依赖型卤素过氧化物酶基因及其编码蛋白
WO2019200025A1 (en)	2018-04-11	2019-10-17	New Mexico Tech University Research Park Corporation	Anti-infective formulations

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3992158A (en)	1973-08-16	1976-11-16	Eastman Kodak Company	Integral analytical element
SE7903361L (sv) *	1978-04-20	1979-10-21	Johnson Matthey Co Ltd	Kompositioner innehallande platina
US4258001A (en)	1978-12-27	1981-03-24	Eastman Kodak Company	Element, structure and method for the analysis or transport of liquids
US4361537A (en) *	1979-01-12	1982-11-30	Thyroid Diagnostics, Inc.	Test device and method for its use
JPS55164356A (en)	1979-06-08	1980-12-22	Fuji Photo Film Co Ltd	Multi-layer analysis sheet for liquid sample analysis
US4301139A (en) *	1979-06-21	1981-11-17	Ames-Yissum Ltd.	Multilayer column chromatography specific binding assay method, test device and test kit
JPS5767860A (en)	1980-10-15	1982-04-24	Fuji Photo Film Co Ltd	Material for multilayer analysis
JPS57101761A (en)	1980-12-17	1982-06-24	Konishiroku Photo Ind Co Ltd	Analyzing element
US4517288A (en)	1981-01-23	1985-05-14	American Hospital Supply Corp.	Solid phase system for ligand assay
JPS57200862A (en)	1981-06-05	1982-12-09	Fuji Photo Film Co Ltd	Mutilayer analysis element utilizing unique binding reaction
US4670381A (en)	1985-07-19	1987-06-02	Eastman Kodak Company	Heterogeneous immunoassay utilizing horizontal separation in an analytical element
US4806311A (en) *	1985-08-28	1989-02-21	Miles Inc.	Multizone analytical element having labeled reagent concentration zone
US4806312A (en) *	1985-08-28	1989-02-21	Miles Inc.	Multizone analytical element having detectable signal concentrating zone
US4997772A (en)	1987-09-18	1991-03-05	Eastman Kodak Company	Water-insoluble particle and immunoreactive reagent, analytical elements and methods of use
US4828978A (en)	1987-09-18	1989-05-09	Eastman Kodak Company	Agglutination reagent and method of preparing same
US5177023A (en)	1987-08-03	1993-01-05	Eastman Kodak Company	Water-insoluble reagent elements containing same and methods of use
DE69026851T2 (de)	1989-02-14	1996-10-31	Wako Pure Chem Ind Ltd	Verfahren zur Erhöhung von Chemilumineszenz
JP3184894B2 (ja) *	1989-10-05	2001-07-09	エックスオックスエミス，インコーポレイテッド	ハロペルオキシターゼ酸至適化学的発光分析系
US5324835A (en)	1990-03-30	1994-06-28	Biosensor Laboratories Co., Ltd.	Pyridazinoquinoxalinones for use as chemiluminescent agents
US5147777A (en)	1990-06-18	1992-09-15	Eastman Kodak Company	Biologically active reagents prepared from carboxy-containing polymer, analytical element and methods of use
CA2056142A1 (en)	1990-11-27	1992-05-28	Hirotomo Masuya	Pyridopyridazine compounds and their use
US5460777A (en) *	1992-03-16	1995-10-24	Fuji Photo Film Co., Ltd.	Analytical element for whole blood analysis
JPH0661273A (ja) *	1992-08-06	1994-03-04	Mitsubishi Electric Corp	リードフレーム処理方法及びそのための装置
US5372932A (en) *	1992-12-22	1994-12-13	Eastman Kodak Company	Analytical element and method for the determination of a specific binding ligand using a 4-hydroxy or 4-alkoxyarylacetamide as stabilizer
US5372931A (en)	1992-12-22	1994-12-13	Eastman Kodak Company	Use of 4'-hydroxy- and 4'-alkoxy-substituted electron transfer agents in compositions, elements, test kits and analytical methods
US5811253A (en) *	1995-09-01	1998-09-22	Johnson & Johnson Clinical Diagnostics, Inc.	Use of vanadium bromoperoxidase as a signal-generating enzyme for chemiluminescent systems: test kits and analytical methods

1996
- 1996-08-16 DE DE69607972T patent/DE69607972T2/de not_active Expired - Fee Related
- 1996-08-16 WO PCT/US1996/013270 patent/WO1997009619A1/en not_active Ceased
- 1996-08-16 CA CA002230802A patent/CA2230802C/en not_active Expired - Fee Related
- 1996-08-16 EP EP96928884A patent/EP0848819B1/de not_active Expired - Lifetime
- 1996-08-16 AT AT96928884T patent/ATE192237T1/de not_active IP Right Cessation
- 1996-08-16 CN CN96197973A patent/CN1113105C/zh not_active Expired - Fee Related
- 1996-08-16 AU AU68476/96A patent/AU714498B2/en not_active Ceased
- 1996-08-16 KR KR10-1998-0701477A patent/KR100383141B1/ko not_active Expired - Fee Related
1997
- 1997-10-17 US US08/953,071 patent/US6322992B1/en not_active Expired - Fee Related
1998
- 1998-02-26 NO NO19980813A patent/NO320625B1/no unknown

Also Published As

Publication number	Publication date
US6322992B1 (en)	2001-11-27
EP0848819B1 (de)	2000-04-26
NO980813L (no)	1998-04-23
AU714498B2 (en)	2000-01-06
CN1113105C (zh)	2003-07-02
KR100383141B1 (ko)	2003-10-24
WO1997009619A1 (en)	1997-03-13
CA2230802C (en)	2008-04-01
CA2230802A1 (en)	1997-03-13
DE69607972D1 (de)	2000-05-31
NO980813D0 (no)	1998-02-26
AU6847696A (en)	1997-03-27
KR19990044241A (ko)	1999-06-25
JPH11512282A (ja)	1999-10-26
EP0848819A1 (de)	1998-06-24
ATE192237T1 (de)	2000-05-15
DE69607972T2 (de)	2000-08-17
JP3727661B2 (ja)	2005-12-14
CN1202247A (zh)	1998-12-16

Publication	Publication Date	Title
EP0171150B1 (de)	1992-03-25	Verfahren und Gerät für Testverfahren mittels fakultativ für Qualität kontrollierter Reagenzien
US5362654A (en)	1994-11-08	Self-contained quantitative assay
EP0247796A1 (de)	1987-12-02	Festphasen-Immuntestverfahren
EP0587222B1 (de)	1999-03-10	Trockene Immunoassay-Elemente mit einer getrennten Absorbierungsschicht
JP4167491B2 (ja)	2008-10-15	全血測定法
JP2851232B2 (ja)	1999-01-27	特異的バインディングリガンドを検出するための分析要素及び方法
EP0270206A1 (de)	1988-06-08	Assays
EP0848819B1 (de)	2000-04-26	Analytisches element und verfahren zur bestimmung eines spezifischen bindenden liganden unter verwendung einer vanadin-bromperoxidase als ein signalgenerierendes enzym
EP1491892A1 (de)	2004-12-29	Testvorrichtung für die chromatographie und verfahren zu dessen herstellung
CA1318588C (en)	1993-06-01	Method and device for separating plasma from red cells
US20070092978A1 (en)	2007-04-26	Target ligand detection
CA2154013C (en)	2006-12-19	Analytical element, composition and method using modified apo-horseradish peroxidase
EP0253581A1 (de)	1988-01-20	Analyseeinheit mit wasserlöslichen Polymeren und damit durchgeführte Bestimmungen
GB2186078A (en)	1987-08-05	Method and apparatus for carrying out biochemical assay
JP3727661B6 (ja)	2006-04-19	シグナル発生酵素としてバナジウムブロモペルオキシダーゼを使った特異的結合リガンドの測定用の分析要素および方法
JP3179673B2 (ja)	2001-06-25	多層乾式イムノアッセイ要素およびイムノアッセイの実施方法
JP2001272405A (ja)	2001-10-05	検査キット
JPH03233360A (ja)	1991-10-17	マルチウエルテスト
EP0603962A1 (de)	1994-06-29	Immunoassay-Elemente, die eine getrennte Rezeptorschicht haben
US20040005627A1 (en)	2004-01-08	Microvolume detecting method and device
JP2002202309A (ja)	2002-07-19	免疫学的検査方法
JPH09229938A (ja)	1997-09-05	抗梅毒トレポネーマ抗体の免疫分析方法及び免疫分析装置
JPH04166765A (ja)	1992-06-12	糞便中のヒトヘモグロビン測定のための装置及び該測定に使用する試薬
JP2004177321A (ja)	2004-06-24	微量検出方法及び装置
CA2005511A1 (en)	1990-07-17	Enzyme-labeled receptor composition, diagnostic kit and use in method to determine a ligand